Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)

NACompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
Vitreoretinal SurgeriesPostoperative Nausea and VomitingPostoperative PainOculocardiac Reflex
Interventions
DRUG

paracetamol

in group P patients will receive pre-emptive analgesia using intravenous infusion of acetaminophen in a single dose of 10-15 mg per kg of body weight

DRUG

0,5 % bupivacaine with of 2% lidocaine

in group BL patients will receive regional peribulbar block using a solution of 0,5% bupivacaine (2,5 ml) with 2% lidocaine (2,5 ml)

DRUG

1 % Ropivacaine

in group R patients will receive regional peribulbar block using a solution of 0,75 % ropivacaine (5 ml)

DRUG

0,5 % bupivacaine

in group B patients will receive regional peribulbar block using a solution of 0,5% bupivacaine (5 ml)

Trial Locations (1)

41-200

Medical University of Silesia, Sosnowiec

All Listed Sponsors
collaborator

Silesian University of Medicine

OTHER

lead

Medical University of Silesia

OTHER

NCT03413371 - Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS) | Biotech Hunter | Biotech Hunter